搜索临床试验以:Exon 20 insertion mutation
总计13176个结果
-
Shaheed Zulfiqar Ali Bhutto Medical University完全的
-
University of North Carolina, Chapel Hill完全的
-
Alexion Pharmaceuticals终止
-
Reata, a wholly owned subsidiary of Biogen撤销2 型糖尿病 | 晚期肾脏疾病
-
Yale UniversityCenters for Disease Control and Prevention主动,不招人
-
University of Colorado, DenverInternational Atomic Energy Agency; Universidad Francisco Marroquín完全的
-
The City College of New YorkNational Cancer Institute (NCI); Virginia Tech Carilion School of Medicine and Research Institute完全的
-
Tel-Aviv Sourasky Medical Center未知
-
Nova Southeastern UniversityAdaptive Sensory Technology完全的
-
Medicines for Malaria VentureNucleus Network Ltd; Southern Star Research Pty Ltd.完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)招聘中
-
Tasly Pharmaceuticals, Inc.Tasly Pharmaceutical Group Co., Ltd不再可用
-
Hospital for Special Surgery, New York招聘中
-
National Heart, Lung, and Blood Institute (NHLBI)完全的
-
University Hospital, Bordeaux终止低位前切除综合征 (LARS>20) | 直肠切除术后难治性药物治疗法国
-
Genuine Research Center, EgyptHikma Pharma完全的
-
Mercy ResearchImpediMed Limited; Mercy Foundation; St. Louis Men's Group Against Cancer; Juzo USA主动,不招人
-
Bristol-Myers Squibb终止
-
Merit Medical Systems, Inc.完全的
-
Mei-fang Huang未知